Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | TNKS | O95271 | 2/20 | 0.33 |
| ▸ | TNKS2 | Q9H2K2 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | ATM | Q13315 | 2/20 | 0.33 |
| ▸ | F9 | P00740 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | PRKDC | P78527 | 1/20 | 0.31 |
| ▸ | GSK3A | P49840 | 1/20 | 0.30 |
| ▸ | GSK3B | P49841 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17307424 | 0.99 | ALOX5 (0.35) | ALOX5MAPTTNKSTNKS2L3MBTL1 | |
| SCHEMBL17307431 | 0.97 | ALOX5 (0.36) | ALOX5MAPTTNKSTNKS2L3MBTL1 | |
| SCHEMBL17307462 | 0.97 | ALOX5 (0.35) | ALOX5MAPTTNKSTNKS2L3MBTL1 | |
| SCHEMBL17307440 | 0.95 | ALOX5 (0.40) | ALOX5MAPTTNKSTNKS2L3MBTL1 | |
| SCHEMBL17307432 | 0.94 | ALOX5 (0.38) | ALOX5MAPTTNKSTNKS2L3MBTL1 | |
| SCHEMBL17307409 | 0.93 | MEN1 (0.35) | ALOX5MAPTTNKSTNKS2L3MBTL1 | |
| SCHEMBL17307450 | 0.93 | ALOX5 (0.37) | ALOX5MAPTTNKSTNKS2L3MBTL1 | |
| SCHEMBL17307421 | 0.92 | MEN1 (0.34) | ALOX5MAPTTNKSTNKS2L3MBTL1 | |
| SCHEMBL17736171 | 0.92 | ALOX5 (0.35) | ALOX5MAPTTNKSTNKS2L3MBTL1 | |
| SCHEMBL17307457 | 0.91 | MEN1 (0.36) | ALOX5MAPTTNKSTNKS2ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9653690-B2 | Organic compound, organic optoelectronic device and display device | SAMSUNG SDI CO., LTD. (KR) | 2017-05-16 | — | — | US | disclosed |
| US-9653690-B2 | Organic compound, organic optoelectronic device and display device | SAMSUNG SDI CO., LTD. (KR) | 2017-05-16 | — | — | US | disclosed |
| US-20150349270-A1 | ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2015-12-03 | — | — | US | disclosed |
| US-20150349270-A1 | ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2015-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150349270-A1 | ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | OCIAD1, OXER1, OR10J3 | ALOX5 798/4885MAPT 2444/4885TNKS 4645/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.